INVO Fertility, Inc. (IVF): debt financing — INVO Bioscience enters $300K convertible debenture and up to $10M equity purchase agreement

INVO Fertility, Inc.

Issued $300K principal convertible debenture to Peak One at $270K purchase price, 8% interest, convertible at $0.52/share.
Issued warrant to buy 150K shares at $0.75 and 50K commitment shares as inducement.
Entered equity purchase agreement for up to $10M of common stock in tranches at 97% of market price.
Proceeds used for working capital and general corporate purposes.
Registration rights agreement requires filing within 90 days for resale of convertible and warrant shares.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

INVO Fertility, Inc. incurred convertible notes of $300,000 with Peak One Opportunity Fund, LP at eight percent (8%) per annum maturing February 3, 2024.

Instrument: convertible notes
Principal: $300,000
Counterparty: Peak One Opportunity Fund, LP
Rate: eight percent (8%) per annum
Maturity: February 3, 2024
Event: incurrence

Exact text from the filing

On February 3, 2023 (the “Closing”), INVO Bioscience, Inc. (the “Company”) entered into securities purchase agreement (“Purchase Agreement”) with Peak One Opportunity Fund, LP, an accredited investor (the “Buyer”) for the purchase of (i) a convertible debenture of the Company (the “Debenture”) in the aggregate original principal amount of $300,000

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INVO Fertility, Inc. entered into Purchase Agreement with Peak One Opportunity Fund, LP (effective 2023-02-03).

Action: entry
Agreement: equity purchase
Counterparty: Peak One Opportunity Fund, LP
Effective: 2023-02-03

Exact text from the filing

On February 3, 2023 (the “Closing”), INVO Bioscience, Inc. (the “Company”) entered into securities purchase agreement (“Purchase Agreement”) with Peak One Opportunity Fund, LP, an accredited investor (the “Buyer”) for the purchase of (i) a convertible debenture of the Company (the “Debenture”) in the aggregate original principal amount of $300,000 (the “Debenture”) for a purchase price of $270,000

View on SEC.gov

90 debt financings filed in the last 30 days. Browse all debt financings →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-004074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.